Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1998
06/02/1998US5759803 Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA
06/02/1998US5759802 Production of human serum alubumin A
06/02/1998US5759801 Δ5,7 -sterol reductase from arabidopsis thaliana
06/02/1998US5759790 Von Hippel - Lindau (VHL) disease gene and corresponding cDNA and methods for detecting carriers of the VHL disease gene
06/02/1998US5759789 Prostaglandin receptor EP2
06/02/1998US5759788 High affinity L-proline transporter polypeptides; antibodies and immunoassays specific for them
06/02/1998US5759784 Method of nucleic acid transfer
06/02/1998US5759783 Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene
06/02/1998US5759778 Method of nucleic acid sequence selection
06/02/1998US5759776 Targets for breast cancer diagnosis and treatment
06/02/1998US5759775 Hybridization; amplification
06/02/1998US5759773 Sensitive nucleic acid sandwich hybridization assay
06/02/1998US5759771 Method of determining a genotype by comparing the nucleotide sequence of members of a gene family and kit therefor
06/02/1998US5759770 Retrovirus from the HIV group and its use
06/02/1998US5759769 Diagnostic kits, vaccines; immobilized peptide having amino acid sequence epitope
06/02/1998US5759553 Polypeptides
06/02/1998US5759552 Marek's disease virus recombinant poxvirus vaccine
06/02/1998US5759546 Treatment of CD4 T-cell mediated conditions
06/02/1998US5759538 Bacillus thuringiensis apr and npr genes, apr and npr B.t. strains, and method of use
06/02/1998US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses
06/02/1998US5759533 Neutrophil-activating peptide-2
06/02/1998US5759519 Method for the intracellular delivery of biomolecules using thiocationic lipids
06/02/1998US5759517 Hemoglobins as drug delivery agents
06/02/1998CA1339894C Fusion proteins with a eukaryotic ballast portion
06/02/1998CA1339893C Procaryotic carbonyl hydrolases
06/02/1998CA1339892C Preparation of polypeptides having human gamma enterferon activity
05/1998
05/29/1998CA2217159A1 Multifunctional ligand system for cell-specific transfer of nucleic acid
05/28/1998WO1998022623A2 Cdna collections encoding proteins regulated during programmed cell death, and methods of use thereof
05/28/1998WO1998022622A1 Method for identifying mutants and molecules
05/28/1998WO1998022610A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
05/28/1998WO1998022609A1 Chimeric adenoviral vectors
05/28/1998WO1998022608A2 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
05/28/1998WO1998022607A1 Method for producing recombinant virus
05/28/1998WO1998022606A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia
05/28/1998WO1998022605A1 Improved methods for transducing cells
05/28/1998WO1998022604A1 Methods of producing high-oil seed by modification of starch levels
05/28/1998WO1998022602A1 Zearalenone detoxification compositions and methods
05/28/1998WO1998022601A1 Heat stable mutants of starch biosynthesis enzymes
05/28/1998WO1998022600A1 Transgenic plant or plants with a naturally high water content overproducing at least two amino acids of the aspartate family
05/28/1998WO1998022599A1 Nematode-inducible regulatory dna sequences
05/28/1998WO1998022598A1 Methods for producing polypeptides in surfactin mutants of bacillus cells
05/28/1998WO1998022597A2 Cloning and characterization of napsin, an aspartic protease
05/28/1998WO1998022596A1 RECOMBINANT VACCINIA VIRUS, PROCESS FOR PREPARING Gag PROTEIN PARTICLE STRUCTURE USING THE SAME, PARTICLE PREPARED BY SAID PROCESS, AND USE THEREOF
05/28/1998WO1998022595A1 Broad-spectrum delta-endotoxins
05/28/1998WO1998022594A1 Compositions and methods for plant pathogen resistance
05/28/1998WO1998022593A1 P gene promoter constructs for floral-tissue preferred gene expression
05/28/1998WO1998022592A1 Agl15 sequences in transgenic plants
05/28/1998WO1998022591A2 Carrot antifreeze polypeptides
05/28/1998WO1998022590A1 Process for preparing antibody molecules
05/28/1998WO1998022589A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998WO1998022588A2 An improved method for the production and purification of adenoviral vectors
05/28/1998WO1998022587A2 Pituitary-tumor-transforming-genes, and related products
05/28/1998WO1998022586A2 HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR
05/28/1998WO1998022585A1 HUMAN POLYHOMEOTIC 2(hph2) ACTS AS AN ONCOGENE
05/28/1998WO1998022584A1 C1q RECEPTOR, ENCODING GENE AND APPLICATION IN HOST DEFENSE ENHANCEMENT
05/28/1998WO1998022583A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION
05/28/1998WO1998022582A1 Human cancer regression antigen protein
05/28/1998WO1998022581A1 Transcription repressor
05/28/1998WO1998022580A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
05/28/1998WO1998022579A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition
05/28/1998WO1998022578A1 Methods for detecting and isolating genes
05/28/1998WO1998022577A1 Fusion proteins having increased half-lives
05/28/1998WO1998022575A2 Nucleotide sequence of escherichia coli pathogenicity islands
05/28/1998WO1998022574A2 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates
05/28/1998WO1998022507A2 Receptor tyrosine kinase genes
05/28/1998WO1998022506A1 Human kdel receptor
05/28/1998WO1998022504A1 Novel semaphorin genes (i)
05/28/1998WO1998022501A2 Secreted proteins and polynucleotides encoding them
05/28/1998WO1998022496A2 Antiviral peptide derivatives
05/28/1998WO1998022492A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998WO1998022491A1 Method for identifying genes encoding novel secreted or membrane-associated proteins
05/28/1998WO1998022489A1 Novel nucleotide analogues
05/28/1998WO1998022438A1 Cyclic imines as pesticides
05/28/1998WO1998022145A1 Immunization of infants
05/28/1998WO1998022144A2 Complexes of adenovirus with cationic molecules
05/28/1998WO1998022143A1 Chimeric retrovirus/adenovirus system
05/28/1998WO1998022142A1 Antisense oligonucleotide compositions for selectively killing cancer cells
05/28/1998WO1998022140A2 Hybrid compositions for intracellular targeting
05/28/1998WO1998022134A1 BIOSYNTHETIC GENE murG FROM $i(STREPTOCOCCUS PNEUMONIAE)
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022104A2 Treatment of neurodegenerative conditions with nimesulide
05/28/1998WO1998021972A2 Compounds with improved inductive effect on cartilage and bones
05/28/1998WO1998021938A1 Glutathione-s-conjugate transport in plants
05/28/1998WO1998016551A3 Variants of vascular endothelial cell growth factor having antagonistic properties
05/28/1998WO1998014611A3 Detection and identification of non-polio enteroviruses
05/28/1998WO1998012328A3 Human bad polypeptides, encoding nucleic acids and methods of use
05/28/1998WO1998007862A3 Chemokine beta-16
05/28/1998WO1998002191A3 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
05/28/1998WO1998001550A3 Vaccine against gastro-intestinal nematodes
05/28/1998DE19648715A1 DNA encoding human interleukin-16
05/28/1998DE19648011A1 Cyclische Imine Cyclic imines
05/28/1998CA2275438A1 Improved methods for transducing cells
05/28/1998CA2272824A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition
05/28/1998CA2272823A1 Method for identifying genes encoding novel secreted or membrane-associated proteins
05/28/1998CA2272747A1 Hybrid compositions for intracellular targeting
05/28/1998CA2272744A1 Chimeric adenoviral vectors
05/28/1998CA2272578A1 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
05/28/1998CA2272564A1 Transgenic plant or plants with a naturally high water content overproducing at least two amino acids of the aspartate family
05/28/1998CA2272545A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998CA2272534A1 Carrot antifreeze polypeptides